case_images: PMC11363906_01
case_images: Preoperative magnetic resonance imaging.
case_images: 0102-6720-abcd-37-e1819-gf01.jpg
case_images: PMC11363906_01_0102-6720-abcd-37-e1819-gf01.jpg
case_images: F1
case_images: Intraoperative ultrasound (a, b and c).
case_images: 0102-6720-abcd-37-e1819-gf02.jpg
case_images: PMC11363906_01_0102-6720-abcd-37-e1819-gf02.jpg
case_images: F2
case_images: This resulted in a significant alteration throughout the entire architecture of the tumor as seen on real-time intraoperative ultrasound (Figure 2).
case_images: Magnetic resonance imaging six months postoperatively.
case_images: 0102-6720-abcd-37-e1819-gf03.jpg
case_images: PMC11363906_01_0102-6720-abcd-37-e1819-gf03.jpg
case_images: F3
case_images: U/L, C-peptide at 1.80 ng/mL, Hb1Ac at 4.8%, and insulin at 7.7 micro-IU/mL. Upper abdominal MRI, performed six months after RFA, displayed a RFA area measuring 1.8x1.7 cm in the anterior part of the body of the pancreas, where the lesion was found before (Figure 3).